Adverse drug events associated with insulin glargine: a real-world pharmacovigilance study based on the FAERS database
database[Title] 2025-05-13
Summary:
CONCLUSION: This study explored the real-world safety of insulin glargine and revealed several unexpected ADEs. These findings provide new insights into the safety profile of insulin glargine for clinicians."